載入...
Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
BACKGROUND: Pemphigus vulgaris (PV) is a blistering, life-threatening autoimmune disease. Ethylenediaminetetraacetic acid (EDTA)-treated desmoglein (Dsg) enzyme-linked immunosorbent assay (ELISA) has recently been suggested to detect nonpathogenic antibodies. Rituximab (RTX) is now considered a firs...
Na minha lista:
| 發表在: | Int J Womens Dermatol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6938821/ https://ncbi.nlm.nih.gov/pubmed/31909160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijwd.2019.05.008 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|